Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Per Erztgaard"'
Autor:
Naseer H J Haboubi, Alexander C. H. Geurts, Robert Prempeh, Jarosław Sławek, Yesim Parman, Jörg Wissel, Peter Schnider, Stefano Cavazza, Thierry Deltombe, Esther Duarte, Djamel Bensmail, Konstantina Petropoulou, Marc Rousseaux, Tatjana Paternostro-Sluga, Anthony B. Ward, Martin J Hecht, Niko Tieranta, Paolo Manganotti, Yesim Kirazli, Jean-Michel Gracies, Helge Kasch, Per Erztgaard, Francisco J. Juan, Thierry Lejeune, Maria C. Altavista, Christian Kätterer
Publikováno v:
Journal of Rehabilitation Medicine, 41, 1, pp. 13-25
Journal of Rehabilitation Medicine, 41, 13-25
Wissel, J, Ward, A B, Erztgaard, P, Bensmail, D, Hecht, M J, Lejeune, T M, Schnider, P, Altavista, M C, Cavazza, S, Deltombe, T, Duarte, E, Geurts, A C H, Gracies, J-M, Haboubi, N H J, Juan, F J, Kasch, H, Kätterer, C, Kirazli, Y, Manganotti, P, Parman, Y, Paternostro-Sluga, T, Petropoulou, K, Prempeh, R, Rousseaux, M, Slawek, J & Tieranta, N 2009, ' European consensus table on the use of botulinum toxin type A in adult spasticity ', Journal of Rehabilitation Medicine, vol. 41, no. 1, pp. 13-25 . https://doi.org/10.2340/16501977-0303
Journal of Rehabilitation Medicine, 41, 13-25
Wissel, J, Ward, A B, Erztgaard, P, Bensmail, D, Hecht, M J, Lejeune, T M, Schnider, P, Altavista, M C, Cavazza, S, Deltombe, T, Duarte, E, Geurts, A C H, Gracies, J-M, Haboubi, N H J, Juan, F J, Kasch, H, Kätterer, C, Kirazli, Y, Manganotti, P, Parman, Y, Paternostro-Sluga, T, Petropoulou, K, Prempeh, R, Rousseaux, M, Slawek, J & Tieranta, N 2009, ' European consensus table on the use of botulinum toxin type A in adult spasticity ', Journal of Rehabilitation Medicine, vol. 41, no. 1, pp. 13-25 . https://doi.org/10.2340/16501977-0303
WOS: 000264016900002
PubMed ID: 19197564
A group of clinicians from across Europe experienced in the use of botulinum toxin type a for the treatment of spasticity following acquired brain injury gathered to develop a consensus statement on
PubMed ID: 19197564
A group of clinicians from across Europe experienced in the use of botulinum toxin type a for the treatment of spasticity following acquired brain injury gathered to develop a consensus statement on
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6594ef2b0051615f8a6bd93a7e7e691d
https://doi.org/10.2340/16501977-0303
https://doi.org/10.2340/16501977-0303